Devices/Recall·openFDA/device

MICROVENTION INC. — Class II: BOBBY Balloon Guide Catheter REF: BOB-895-CN BOB-895-EMEA BOB-895-EMEA-AL BOB-895-US

MediumPublished Aug 19, 2026· AI-analyzed Aug 25, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

MicroVention Inc. has initiated a Class II recall for the BOBBY Balloon Guide Catheter due to an increased rate of balloon pinhole defects. The affected products include multiple reference numbers (BOB-895-CN, -EMEA, -EMEA-AL, -US, and MV-BGA01095) used for intravascular catheter guidance.

Who it affects

This recall affects MicroVention Inc., healthcare providers using the BOBBY Balloon Guide Catheter in peripheral and neurovascular systems, and internal quality and regulatory teams responsible for catheter manufacturing and distribution.

Why it matters

The identification of pinhole defects in a balloon guide catheter suggests potential compromises in the device's ability to maintain pressure or facilitate proper vessel guidance. For regulatory professionals, this indicates a failure in manufacturing quality or material integrity that necessitated an ongoing recall to mitigate patient risk during neurovascular procedures.

Practical takeaway

QA and Clinical teams should immediately verify inventory against the specified REF numbers (BOB-895 series) and MV-BGA01095. Regulatory departments should assess existing Post-Market Surveillance data for similar balloon integrity issues and ensure CAPA processes address the root cause of the pinhole defects.

FDA source material

Class II. Reason: Due to an increase rate of balloon pinhole defects.. Product: BOBBY Balloon Guide Catheter REF: BOB-895-CN BOB-895-EMEA BOB-895-EMEA-AL BOB-895-US MV-BGA01095 For use in facilitating the insertion and guidance of an intravascular catheter into a selected blood vessel in the peripheral and neurovascular systems.. Firm: MICROVENTION INC. (Aliso Viejo CA United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.